Cargando…
Cost‐Effectiveness of Cardiovascular, Obesity, and Diabetes Mellitus Drugs: Comparative Analysis of the United States and England
Autores principales: | Cherla, Avi, Renwick, Matthew, Stefanini, Giulio, Holmes Jr, David R., Mossialos, Elias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763410/ https://www.ncbi.nlm.nih.gov/pubmed/33121302 http://dx.doi.org/10.1161/JAHA.120.018281 |
Ejemplares similares
-
Cost-effectiveness of cancer drugs: Comparative analysis of the United States and England
por: Cherla, Avi, et al.
Publicado: (2020) -
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
por: Cherla, Avi, et al.
Publicado: (2021) -
Post‐Marketing Requirements for Cancer Drugs Approved by the European Medicines Agency, 2004–2014
por: Cherla, Avi, et al.
Publicado: (2022) -
A Framework for Digital Health Policy: Insights from Virtual Primary Care Systems Across Five Nations
por: Srivastava, Divya, et al.
Publicado: (2023) -
A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics
por: Renwick, Matthew J, et al.
Publicado: (2016)